HeartSciences Inc. (HSCS)
2025-07-31 | 2024-10-31 | |||
|---|---|---|---|---|
| Revenue | 1,900 | - | ||
| Cost of sales | 760 | - | ||
| Gross margin | 1,140 | - | ||
| Selling, general and administrative | 878,053 | 786,068 | ||
| Research and development | 997,206 | 1,198,965 | ||
| Total operating expenses | 1,875,259 | 1,985,033 | ||
| Loss from operations | -1,874,119 | -1,985,033 | ||
| Other income | 2,813 | 19,713 | ||
| Interest expense | 183,688 | 117,598 | ||
| Total other income (expense), net | -180,875 | -97,885 | ||
| Net loss | -2,054,994 | -2,082,918 | ||
| Earnings per share, basic, total | -1.58 | -2.27 | ||
| Earnings per share, diluted, total | -1.58 | -2.27 | ||
| Weighted average number of shares outstanding, basic, total | 1,303,532 | 917,445 | ||
| Weighted average number of shares outstanding, diluted, total | 1,303,532 | 917,445 | ||